Indoco Remedies has received the final USFDA approval of its ANDA for Febuxostat Tablets 40 mg and 80 mg, which is therapeutically equivalent to the reference listed drug (RLD), viz., Uloric Tablets 40 mg and 80 mg of Takeda Pharmaceuticals U.S.A., Inc.